your link shows where it was approved, those aren't usage numbers,
> ... there should be a preference for an alternative to the AstraZeneca [1]
> Canada’s largest province says it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots [2]
> More nations halt use of AstraZeneca's COVID vaccine citing clots [3]
> your link shows where it was approved, those aren't usage numbers.
False. Here's the note on the image showing vaccine usage:
"Note: The Oxford-AstraZeneca vaccine is known as Covishield in India. Only countries that report doses administered are shown. Other countries may have approved vaccines but have not administered them yet."
> ... there should be a preference for an alternative to the AstraZeneca [1]
> Canada’s largest province says it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots [2]
> More nations halt use of AstraZeneca's COVID vaccine citing clots [3]
[1] https://www.gov.uk/government/publications/use-of-the-astraz...
[2] https://abcnews.go.com/International/wireStory/canadas-large...
[3] https://www.msn.com/en-us/news/world/more-nations-halt-use-o...